top of page
Search

Combination for Treating Mesothelioma Approved

“Approval of nivolumab plus ipilimumab provides a new treatment that has demonstrated an improvement in overall survival for patients with malignant pleural mesothelioma,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research. “In 2004, FDA approved pemetrexed in combination with cisplatin for this indication, and now patients now have an important, additional treatment option after more than a decade with only one FDA-approved drug regimen.” Read More

17 views

Recent Posts

See All

Commentaires

Noté 0 étoile sur 5.
Pas encore de note

Ajouter une note
bottom of page